EUVIMEDEUVIMED entdecken
Crossref

L26/P-147 Granulocyte–macrophage colony-stimulating factor–supplemented embryo culture and reproductive outcomes in patients with previous failed IVF attempts undergoing frozen–thawed embryo transfer

M. Isik, A.Z. Isik, C.B. Bulbul Hanedar, D. Akıncı

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.483 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M. Isik und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Is granulocyte–macrophage colony-stimulating factor (GM-CSF)–supplemented embryo culture associated with improved fertilization and clinical outcomes in patients with previous failed attempts undergoing frozen–thawed embryo transfer? Summary answer GM-CSF–supplemented embryo culture was associated with significantly higher fertilization rates and a positive trend toward improved pregnancy outcomes, without an effect on miscarriage rates. What is known already In vitro fertilization (IVF) culture media aim to mimic the physiological environment of the female reproductive tract; however, current systems lack many maternally derived cytokines and growth factors present in vivo. GM-CSF is secreted by the fallopian tube and endometrium and plays a key role in early embryonic development, implantation, and placentation. Preimplantation embryos express GM-CSF receptors but are unable to synthesise GM-CSF themselves, making them dependent on maternal supply. Experimental and clinical studies suggest that GM-CSF supplementation may enhance blastocyst quality, reduce apoptosis, and improve reproductive outcomes, particularly in patients with recurrent IVF failure. Study design, size, duration This retrospective cohort study was conducted at a private IVF centre and included women undergoing FET between May 2024 and November 2025. Thirty-three women with previous failed IVF attempts undergoing FET received embryos cultured in GM-CSF–supplemented medium. A control group of 54 women treated during the same period underwent standard culture conditions. Not all patients fulfilled strict definitions of recurrent implantation failure; however, all had experienced at least one prior failed IVF attempt. Participants/materials, setting, methods Women ≤42 years with ≥4 high-quality Day-3 embryos were eligible for the study. Day-3 or Day-5 embryos were cryopreserved and, after warming, cultured for ≥4 hours either in GM-CSF–supplemented or conventional medium before transfer. Reproductive outcomes were compared between GM-CSF and control groups. Continuous variables were analyzed using independent-samples t-tests, and categorical variables were compared using chi-square or Fisher’s exact tests. A two-sided p value < 0.05 was considered statistically significant. Main results and the role of chance The fertilization rate was significantly higher in the GM-CSF group compared with controls (89.2% vs. 79.4%, p = 0.009). The ongoing pregnancy and live birth rate was higher in the GM-CSF group (54.5% vs. 37.0%; RR 1.47, 95% CI 0.92–2.34), indicating a positive trend that did not reach statistical significance (p = 0.11). Among patients achieving pregnancy, miscarriage rates were comparable between groups (28.0% vs. 20.0%, p = 0.74). Baseline characteristics were similar between the GM-CSF and control groups, with no significant differences in female age (33.6 ± 5.6 vs. 32.9 ± 5.8 years, p = 0.61), body mass index (24.4 ± 4.2 vs. 24.9 ± 4.7 kg/m², p = 0.71), number of treatment cycles (2.69 ± 1.26 vs. 2.63 ± 0.98, p = 0.83), or embryos transferred per cycle (1.36 ± 0.49 vs. 1.47 ± 0.50, p = 0.38). The observed trend in ongoing pregnancy and live birth outcomes may partly reflect chance variation, particularly given the moderate sample size. Limitations, reasons for caution The retrospective design and relatively small sample size limit statistical power, which may explain the lack of statistical significance for ongoing pregnancy and live birth outcomes. Additionally, the study population did not meet strict recurrent implantation failure criteria, potentially limiting generalizability. Longer follow-up is required to confirm reproductive outcomes. Wider implications of the findings GM-CSF–supplemented embryo culture may represent a promising approach, as it was associated with significantly higher fertilization rates and a positive trend toward improved pregnancy outcomes in patients with previous failed IVF attempts. These findings support further prospective, adequately powered studies to clarify effects on live birth rates and patient selection. Trial registration number No

Zitieren

APA

Isik, M., Isik, A., Hanedar, C. B., & Akıncı, D. (2026). L26/P-147 Granulocyte–macrophage colony-stimulating factor–supplemented embryo culture and reproductive outcomes in patients with previous failed IVF attempts undergoing frozen–thawed embryo transfer. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.483

Vancouver

Isik M, Isik A, Hanedar CB, Akıncı D. L26/P-147 Granulocyte–macrophage colony-stimulating factor–supplemented embryo culture and reproductive outcomes in patients with previous failed IVF attempts undergoing frozen–thawed embryo transfer. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.483

BibTeX
@article{Isik2026,
  author = {Isik, M. and Isik, A.Z. and Hanedar, C.B. Bulbul and Akıncı, D.},
  title = {L26/P-147 Granulocyte–macrophage colony-stimulating factor–supplemented embryo culture and reproductive outcomes in patients with previous failed IVF attempts undergoing frozen–thawed embryo transfer},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.483}
}
Kostenlos starten →